When patient safety, regulatory approval and real-world effectiveness are on the line, AI can't act autonomously.
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
The drug development process faces challenges of efficiency and overall sustainability due in part to high research costs, lengthy development timelines, and late-stage drug failures. Novel clinical ...
Bari Kowal, Senior Vice President, Development Operations & Portfolio Management at Regeneron Clinical trial innovation is a hot topic, but it’s not a new one. The first fully virtual randomized trial ...
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...
In the ultracompetitive world of drug development, getting a new medication on the market as fast as possible can have major ...
Zacks Investment Research on MSN
Healthcare ETFs in Spotlight Amid Eli Lily's $2.8B AI Drug Move
U.S. pharma giant Eli Lilly LLY has just thrust the rapidly evolving field of artificial intelligence (AI)-driven drug ...
The drug development process faces challenges of efficiency and overall sustainability due in part to high research costs, lengthy development timelines, and late-stage drug failures. Novel clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results